Evolving paradigms in primary biliary cholangitis: from molecular mechanisms to personalized therapeutics with seladelpar, elafibranor, and beyond. - Qasim, Bushra; Kumari, Hina; Kashif, Syeda Naveera; Abbas, Syed Muhammad Iraj; Hani, Omme; Salma, Omme; Sauleh, Ahsan; FNU Adnan; Ali, Mashooque; Raheem, Abdul; Arifi, Muhammad Arif; Muhammad, Faqeer; et al. (Egyptian Liver Journal, 2025)